Shingles Vaccine May Not Be Cost Effective For 50-Year-Olds (FREE)
By Jenni Whalen
Edited by David G. Fairchild, MD, MPH
The herpes zoster vaccine does not appear to be cost-effective for adults in their 50s, according to a study from the Annals of Internal Medicine.Researchers collected …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Herpes | Internal Medicine | Primary Care | Shingles | Shingles (Herpes Zoster) Vaccine | Study | Vaccines | Varicella-Zoster Virus Vaccine